One-third of diagnoses reported this year stem from one county in west Texas
US pharma giant seeks to expand footprint beyond cancer treatment as its biggest product nears patent cliff
Researchers develop blood tests to study ‘biological age’ of the body’s organs and tissues
There can be no either/or in mental health — we must rigorously examine pharmaceutical and social solutions
Swiss pharma group says lack of provision for small infants has led to ‘treatment gap’ in deadly disease
Focusing on artificial dyes and seed oils misses the true culprit — excess toxic fat
The US appears to be turning its back on a scientific consensus that has relegated several diseases to history
More than a dozen nations struggle to contain outbreak as health systems flounder with loss of international support
Mebufotenin benzoate also requires a much shorter period of clinical supervision in trial
Research offers clues to choosing chemotherapy treatments with fewer long-term side effects
Slashed US aid agency’s funding is expected to harm the fight against diseases including malaria and HIV/Aids
Move exacerbates Gavi’s struggles with fundraising
Oxford research shows adjuvant chemicals included in vaccinations may enhance their antiviral effect
The decline in funding for vaccinations poses a worldwide threat
Vaccine businesses seen as valuable parts of pharma groups but government hostility could deter future developments
Participants in trial of amycretin injectable obesity drug lost an average of 24% of their body weight on highest dose
Lancet study underscores fears over potential impact of President Trump’s plan to nearly halve funding in 2025
With the NHS in triage mode, business and society need to shift to prevention of ill health
In this monthly series, running alongside our existing Tech Exchange dialogues, FT journalists talk to the scientists, developers and business leaders exploring ever more applications for artificial intelligence, in every aspect of our lives
Cambridge start-up CMR Surgical has innovative technology but it needs global ambition
$140mn financing will allow Draig Therapeutics to move drug candidates into clinical trials
Ruling that NIH’s refusal to pay grants was illegal could lead to funds being reinstated
Expansion of NHS app comes as part of government’s 10-year plan for health service
Partnership gives group access to CSPC’s AI platform for discovering and optimising treatments
Paris conference urges international action against synthetic organisms that could disrupt critical ecosystems
